Schwartz Jonathan David — SEC Form 4 filings

SEC reporting owner CIK 1726398. 8 Form 4 filings on record with FilingPulse; latest filed 2025-11-20.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2025-02-13 to 2025-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ROCKET PHARMACEUTICALS, INC. (RCKT)See Remarks810 legs · 33,667 sh · $288,3043

Form 4 filings — Schwartz Jonathan David

FiledFormIssuerReported transactionsSource
2025-11-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,545 @ $2.98EDGAR
2025-09-094ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 80,000 @ $0EDGAR
2025-08-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,680 @ $3.06 · Sale (S): 805 @ $3.00EDGAR
2025-08-184ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 11,161 @ $3.02EDGAR
2025-05-224ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 801 @ $6.45EDGAR
2025-05-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,582 @ $6.53EDGAR
2025-02-274ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,754 @ $23.35 · Sale (S): 2,710 @ $18.50 · Sale (S): 3,097 @ $13.05 · Sale (S): 6,532 @ $10.58EDGAR
2025-02-134ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 80,318 @ $0 · Grant/award (A): 119,682 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1726398 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →